Ulonivirine

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameUlonivirine
Drug Alias NameMK-8507
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNon-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHepatic InsufficiencyHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[12] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme LLC
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsHepatic InsufficiencyHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A